| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.26 | 3e-10 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.33 | 4e-10 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.25 | 6e-09 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.24 | 1e-08 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.31 | 1e-07 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.29 | 1e-07 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-07 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-06 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.18 | 1e-05 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-05 |